FLS FLOWSERVE CORP Insider Trading

Director McMurray buys 2,500 shares of FLS at $65.71, totaling $164,275.00, lifting holdings +44.1% to 8,172 shares amid -26.5% 90-day price decline.

Director McMurray Michael C. purchased 2,500 shares of Flowserve Corp (FLS) at $65.71 on 2026-05-18 for a total of $164,275.00, increasing his post-transaction holdings to 8,172 shares — a +44.1% increase over his pre-transaction holdings of 5,672 shares. This purchase comes as FLS shares are -28.6% from their 52-week high of $92.41, with a 30-day change of -21.3% and a 90-day change of -26.5%, placing the transaction price of $65.71 near the lower end of the 52-week range of $45.11–$92.41. The company reported net income of $81,681,000.00 and carries a P/E of 23.81 with a market cap of $8,430,151,105.16. McMurray's cross-ticker track record consists of 1 prior sell with an average 90-day return of -5.2%, though that single data point is insufficient to establish a reliable pattern of outcomes across tickers.

Director Savoy buys 1,000 FLS shares at $67.34; stock down 29.6% from 52-week high, holdings rise to 3,573 shares.

Brian D Savoy, a director, purchased 1,000 shares of Flowserve at $67.34 on 2026-05-14, increasing his holdings from 2,573 to 3,573 shares (+38.9% increase in position size). The purchase occurs when FLS is -29.6% from its 52-week high of $92.41 and has fallen -17.4% over the past 30 days and -27.4% over 90 days. Across Savoy's cross-ticker open-market history, his 2 prior sales achieved a 100.00% well-timed rate (meaning his prior sales preceded subsequent stock declines), with an average 90-day return after those sales of -2.8%. This buy, made at a substantially depressed price point relative to recent history, occurs within a company of reasonable fundamentals (P/E 23.49, net income $81.7M, market cap $8.3B), though the near-term price action raises questions about near-term company or market headwinds.

FLS CEO Rowe sells 212.7K shares for $15.0M in 3 transactions; holds 346.6K remaining after 38.0% reduction.

Robert Scott Rowe, President & CEO of Flowserve Corp, executed three separate sales on 2025-12-02 totaling 212,683 shares for $14,989,331.83 at a blended average price of $70.48, reducing his holdings by 38.0% from 559,313 to 346,630 shares. The sale occurred near the company's 52-week high of $71.85 (-1.3% from peak), with the stock up 30.0% over 90 days. Notably, Rowe's same-ticker history at FLS shows 3 prior sells that were all well-timed at the 90-day mark, with each followed by declines (-2.1%, -2.9%, -5.5%), establishing a consistent pattern of favorable sale timing at this ticker. The current filing's substantial reduction in the CEO's equity stake—accomplished in multiple tranches at elevated valuations—warrants attention given the demonstrated pattern and the magnitude of this particular liquidation relative to his remaining position.

CFO Schwetz sold 47,000 FLS shares at $71.02 ($3.3M); post-sale holdings drop to 52,628 shares (-47.2%)

CFO Amy B Schwetz executed a material reduction in her Flowserve position, selling 47,000 shares (47.0K shares) at $71.02 on 2025-11-04 for $3,337,940.00, cutting her holdings by 47.2% from 99,628 shares to 52,628 shares. The transaction occurred near the 52-week high of $71.85, with the stock currently at $69.90 and having appreciated significantly over the past 90 days (+33.5%). The sale size—nearly half her prior stake—represents a substantial capital distribution at a price point near peak valuation levels. Investors should track whether this substantial reduction reflects a shift in the CFO's conviction regarding the company's near-term prospects, though the lack of additional disclosed context limits definitive interpretation.

Hudson (CLO) sold 10,667 shares of FLS at $70.01, reducing stake by -61.8% to 6,589 shares held

Hudson Susan Claire, Chief Legal Officer of Flowserve Corp, executed a sale of 10,667 shares at $70.01 on 2025-11-04, reducing her holdings from 17,256 shares to 6,589 shares—a 61.8% reduction in position. The transaction occurred near the 52-week high of $71.85 and coincides with a 30-day price appreciation of 33.2%, suggesting the sale followed a strong recent run-up in the stock. The company's fundamentals show net income of $219.6M with a market cap of $8.9B, indicating a profitable, substantial enterprise. This substantial reduction in holdings by a senior legal officer merits attention as a material change in insider stake, though the lack of additional context regarding timing constraints or execution scheduling limits definitive motivation inference.

FCD President Wilson Kirk sold 10,000 FLS shares at $53.22 on 2025-08-12; stock now $53.18.

Wilson Kirk, President of FCD, sold 10,000 shares of FLOWSERVE CORP for $532,200.00 on 2025-08-12, reducing his holdings by 21.2% from 47.2K to 37.2K shares. His cross-ticker track record shows 2 prior sells with an average 90-day return of +17.5%, but his well-timed rate at the 90-day mark is 0.00%, indicating those prior sales occurred before subsequent stock appreciation rather than declines. At this specific ticker (FLS), his prior sale on 2024-02-26 also yielded a +17.5% 90-day return, suggesting a pattern of selling into strength. The current price of $53.18 is 17.9% below the 52-week high of $64.75, placing the transaction near recent trading ranges rather than at an obvious inflection point.

FLS President Wilson Kirk sold 10,000 shares ($525.8K) at $52.58; holds 47,196 shares post-sale, -17.5% reduction.

Wilson Kirk, President of FCD, sold 10,000 shares of Flowserve at $52.58 on 2025-08-08, reducing his holdings from 57.2K to 47.2K shares—a -17.5% reduction in his position. The transaction occurred at a price currently -19.4% below the 52-week high of $64.75 and near the 52-week midpoint, with the stock down 2.7% over the prior 30 days. His one prior sale at Flowserve on 2024-02-26 posted a 90-day return of +17.5%, meaning the stock rose after that prior sale. The current sale price of $52.58 compares to today's price of $52.18, showing minimal movement since the transaction date. With P/E at 23.40 and market cap of $6.8B, the company maintains a reasonable valuation, though the timing and magnitude of this sell warrant observation against any upcoming company-specific announcements or guidance shifts.